Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 10 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
New COVID-19 vaccine Novavax offers alternative option in El Paso
The El Paso Times via Yahoo News· 8 months agoThe U.S. Food and Drug Administration approved the updated Novavax vaccine on Tuesday, allowing a...
Novavax sinks on concerns about COVID vaccine maker's prospects
Reuters via Yahoo News· 1 year agoNovavax Inc's shares plunged to a three-year low on Wednesday, a day after the COVID-19 vaccine...
Novavax has its sights set on the commercial COVID-19 vaccine market
Yahoo Finance· 2 years agoNovavax isn't swayed by the negative perceptions and delays in reaching the. market in the U.S., and...
When will Novavax's vaccine be available, and how can I get it?
CBS News via Yahoo News· 2 years agoThe Biden administration is warning states to prepare for a "limited supply" of Novavax's COVID-19...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 1 month agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Who should get the new COVID vaccines? What to know about the 2023-2024 shots
Live Science via Yahoo News· 9 months agoA syringe is filled with Pfizer-BioNTech Covid-19 vaccine by a woman in blue surgical gloves. Like...
Novavax cuts full-year revenue forecast again amid weak demand
Reuters via Yahoo Finance· 2 years agoThe company now expects annual revenue to be near the low end of its prior forecast range of between...
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 2 months agoIn just the past 12 months, Novavax (NASDAQ: NVAX) stock has plummeted 48% in value. The...